Martin Edelman, MD, Talks About Improving Outcomes in the Management of NSCLC
Martin Edelman, MD, Greenbaum Cancer Center, Baltimore, MD, says that organizations like NCCN and ASCO have guidelines for the management of non-small cell lung cancer (NSCLC). "I think that by utilizing these various clinical as well as biological markers, we can develop therapies that are tailored to the individual patient and have substantial evidence to support their use," said Dr Edelman.
This video was taken on May 2, 2013, at the NAMCP Spring Managed Care Forum in Orlando, FL.
The FDA today granted accelerated approval to olaparib, a poly ADP-ribose polymerase (PARP) inhibitor, for treatment of advanced ovarian cancer in women with defected BRCA genes, along with a companion diagnostic test that marked the agency’s first approval of a laboratory developed test (LDT) under a premarket approval application.
Fresh off re-election, Governor Robert Bentley moved this week to name 6 groups to coordinate managed care in Medicaid, as part of a cost-saving strategy he launched in 2012. But the bigger news has been his reversal on expanding the program; as in other Southern states, hospitals have been pressing for the change to solve fiscal problems.
In this segment, the panelists analyze current programs that aim to educate and guide key stakeholders through the facets of cancer care and conclude that collaboration can help control costs and drive quality.
All medical illnesses have issues with nonadherence and part of the reason is because the American health system doesn’t provide the right education, support, and close follow-up needed to get the right medicine to the right person, Wayne Katon, MD, said.
Wayne Katon, MD, addresses the concern of overdiagnosis in mental health, which results in an overuse of drugs like Prozac for people with minor depression. He attributed the problem to the fact that primary care physicians have difficulty getting people into the therapy they need and have to result to medications.